Indivior | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
AstraZeneca USD 5.23B 258M 2025-03
Divis Laboratories Ltd 4.15B 31.87B 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Halozyme Therapeutics USD 176.33M 60.48M 2025-03
Indivior 372M 53M 2025-03
J&J USD 38.47B 32.35B 2025-03
Kyowa Hakko Kirin JPY 214.37B 30.31B 2025-03
Merck USD 8.63B 4.61B 2025-03
Novartis USD 11.46B 2.15B 2024-12
Pfizer USD 1.43B 387M 2025-03
Sanofi 7.44B 646M 2024-12
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12



Indivior Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.